Skip to content
Screener

Kimberly-Clark KMB Bridge fees

Bridge fees at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$17.49M
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$17.49M
OGS
ONE GASOGS
$60M0.0%
FBR
Franklin BSP Realty TrustFBRT
1%+0.5pp
FBR
Franklin BSP Realty TrustFBRT
$401M
Extra Space Storage logo
Extra Space StorageEXR
-$8.29M+15.4%

Other financials

Income statement

See full
Revenue$4.2B+0.6%
Gross profit$1.6B+10.1%
Operating income$633.0M+6.9%
Net income$345.0M-32.2%
EPS (diluted)$1.04-32.0%

Balance sheet

See full
Cash & equivalents$956.0M+50.8%
Total debt$6.5B-10.0%
Total equity$1.9B+47.4%
Total assets$18.6B+10.6%

Cash flow

See full
Operating cash flow$908.0M+17.9%
CapEx$352.0M+78.7%
Free cash flow$556.0M-3.0%

Valuation

See full
Market cap$37.37B-17.6%
Enterprise value$42.93B-17.4%
P/E19.1×+0.5×
P/S2.3×-0.5×

Profitability

See full
Gross margin36.8%+0.5pp
Operating margin15.2%-1.0pp
Net margin11.8%-3.0pp
FCF margin11%-1.8pp

Returns & leverage

See full
Return on equity124.3%-77.6pp
Debt / equity3.5×-2.2×
Current ratio0.9×+0.1×

Where this comes from

Reported directly by Kimberly-Clark in its filing.

Tagged under the XBRL concept kmb:BridgeFeesNet.

The source filing: Kimberly-Clark’s 10-K, filed February 12, 2026.

Filed
Feb 12, 2026, 1:06 PM EST
Fiscal year
FY2025
Accession
0001628280-26-007567

In November 2025, in connection with the Merger Agreement discussed in Note 4, the Company and JPMorgan Chase Bank, N.A. (the "Bank") executed a certain bridge loan facility commitment letter, pursuant to which the Bank has committed to provide bridge financing (the "Bridge Facility") in an amount of $7.7 billion to the Company to fund the Cash Consideration, the fees, costs and expenses incurred in connection with the transactions contemplated by the Merger Agreement and to repay certain existing indebtedness of Kenvue and/or its subsidiaries. In December 2025, $3.8 billion of the commitments in the Bridge Facility were terminated in connection with entry into the New Revolving Credit Facility and DDTL Credit Facility (as defined below). We incurred debt issuance costs of $15 in connection with the Bridge Facility, of which $8 was charged to earnings in connection with the termination of a portion of the commitments. The remaining unamortized amount is capitalized in Other current assets.

ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Kimberly-Clark's bridge fees?
Kimberly-Clark (KMB) reported bridge fees of $2M in Q4 2025.
What does bridge fees mean?
The net expense recognized in the income statement related to bridge loan fees, accounting for amortization or adjustments to the initial capitalized amounts. This represents the ongoing cost of maintaining short-term financing arrangements.

Ask your AI about Kimberly-Clark's bridge fees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude